Youngwoo Jang retweeted
Biotech firm Celularity going public after merger with acquisition company | ROI-NJ roi-nj.com/2021/01/08/health…
Youngwoo Jang retweeted
Celgene's cell therapy spinout nets $292M from blank-check merger biopharmadive.com/news/celul… via @BioPharmaDive @celularity @PeterDiamandis @TonyRobbins
Youngwoo Jang retweeted
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy prnewswire.com/news-releases…
Youngwoo Jang retweeted
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy finance.yahoo.com/news/celul… via @Yahoo @celularity @PeterDiamandis @TonyRobbins #NKcells #immunotherapy
Youngwoo Jang retweeted
Top 30 Stem cells startups medicalstartups.org/top/stem…
Youngwoo Jang retweeted
Could not agree more! The truth is that chronic infection is a signal of a defective immune system either causal or consequential to the infection. Cellular immunotherapy offers a new angle for treatment. @celularity
Youngwoo Jang retweeted
Vitamin D deficiency raises COVID-19 infection risk by 77%, study finds upi.com/7035345t via @upi
Youngwoo Jang retweeted
#convalescentplasma in the absence of functional cellular immunity driven by #nk and #TCELL is like fuel put in the gas tank of a car without an engine. Now is the time for combination therapies @celularity
There is no evidence backing the use of convalescent plasma to treat #COVID19 patients, according to an @NIH panel, led by Dr. Roy M. Gulick of @WCM_ID and @nyphospital and colleagues. Via @maggiemfox of @CNN.
cnn.it/31Zw2Ub
Youngwoo Jang retweeted
Vitamin D deficiency raises #COVID-19 infection risk by 77%, study finds
As many as one in four of the nearly 500 participants in the study were found to have less-than-optimal levels of vitamin D, the data showed.
upi.com/Health_News/2020/09/…
Youngwoo Jang retweeted
Replying to @Lifebankusa @LifebankU
Over 20 years of experience cryopreserving cells for families!
Youngwoo Jang retweeted
Celularity announces the activation of first California Clinical Trial Site following CIRM Grant Award to Advance ... prn.to/39VdFCa
Youngwoo Jang retweeted
Thrilled to see this great progress
FAST, CHEEP (at scale) and ACCURATE! Sorrento Therapeutics CEO on the company's #COVID19 30 minute saliva test youtu.be/AJdc_QL5y30. #coronavirus #long @DrBobHariri
Youngwoo Jang retweeted
Celularity announces the activation of first California Clinical Trial Site following CIRM Grant Award to Advance Treatments for COVID-19 prn.to/39VdFCa
Youngwoo Jang retweeted
Tonight I get to join this amazing panel to talk about the future of therapeutics for #Covid @celularity @FansSorrento @PeterDiamandis @johnsculley @drdavidsamadi @LifebankU @GovernorPerry @jpkiekens @NanHayworth @StemCellMarket @ExponentialMed @MariaBartiromo @JudgeJeanine
TOMORROW NIGHT at 9PM ET! Be sure to tune in to 'Justice'! @GOPLeader @DarrellIssa @TheLeoTerrell Dr. Robert Hariri and @RubinReport will be on. You won't want to miss it!
Youngwoo Jang retweeted
With #COVID19 still claiming lives at an alarming level I am pleading that more attention be directed towards developing therapies @celularity @FansSorrento @StemCellMarket and that attention needs to include financial support.
Youngwoo Jang retweeted
Because of the products we offer, we always look at ourselves as becoming a part of your family. And on this day we want to let our family know we value them. Comment and let us know how we are doing.
Youngwoo Jang retweeted
Heartbreaking, Sir. Thank you for sharing and allowing me to be one more who will remember him.
Youngwoo Jang retweeted
Also, the CDC records any positive topical detection of Coronavirus as a case. A case does not equate to an illness from the virus and is a measure easily misinterpreted. A rise in cases is a function of increased testing. That’s all.















